Hostname: page-component-66644f4456-swwnq Total loading time: 0 Render date: 2025-02-12T13:39:05.825Z Has data issue: true hasContentIssue false
  • English
  • Français

Treatment of Mania with the Cholinomimetic Agent RS 86

Published online by Cambridge University Press:  29 January 2018

J. C. Krieg  and
M. Berger
J. C. Krieg
Affiliation:
Max Planck Institute of Psychiatry Kraepelinstr. 10 D-8000 München 40 West Germany
M. Berger
Affiliation:
Max Planck Institute of Psychiatry Kraepelinstr. 10 D-8000 München 40 West Germany
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 148 , Issue 5 , May 1986 , pp. 613
Copyright
Copyright © 1986 The Royal College of Psychiatrists 

References

Janowsky, D. S., El-Yousef, M. K., Davis, J. M. & Sekerke, H. J. (1972) A cholinergic-adrenergic hypothesis of mania and depression. Lancet, ii, 632–635.CrossRefGoogle Scholar
Lorr, M. (1974) Assessing psychotic behaviour by the IMPS. In Psychological Measurements in Psychopharmacology (eds. Pichot, P. & Olivier-Martin, R.). Basel: Karger.Google Scholar
Spiegel, R. (1984) Effects of RS 86, an orally active cholinergic agonist, on sleep in man. Psychiatry Research, 11, 1–13.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.